Trial Profile
A study to investigate the pharmacokinetics Lenalidomide in Japanese patients with multiple myeloma.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Pharmacokinetics
- 05 Dec 2015 New trial record